)

RAPT Therapeutics (RAPT) investor relations material
RAPT Therapeutics Stifel Virtual Immunology and Inflammation Forum summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and lead asset
Focus on developing high-value therapeutics for inflammatory disorders, targeting large markets in food allergy and chronic spontaneous urticaria.
Lead asset RPT-904, a next-generation anti-IgE antibody, in-licensed from Gemincare, is in phase 2 development.
RPT-904 aims to improve upon omalizumab (Xolair) with better dosing convenience and broader patient coverage.
Portfolio includes a next-generation CCR4 antagonist, with a new candidate selected and advancing toward the clinic.
RPT-904 deal terms and market opportunity
$35 million upfront payment, up to $670 million in milestones, with $450 million as commercial milestones.
Royalty rates reach low double digits; rights are worldwide except China.
Food allergy and urticaria markets estimated at $40 billion and $5 billion, respectively.
Over 60,000 patients on Xolair for food allergy within a year of approval, indicating high unmet need.
Differentiation and competitive landscape
RPT-904 designed for longer half-life (YTE mutation), improved affinity, and less frequent dosing (Q8 or Q12 weeks vs. Q2 weeks for Xolair).
Shares the same epitope as omalizumab, unlike failed competitor ligelizumab, supporting higher confidence in efficacy.
Competitive landscape includes other IgE antibodies and novel approaches, but RPT-904 is among the most advanced.
Next RAPT Therapeutics earnings date

Next RAPT Therapeutics earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage